Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Evotec SE (EVO)

$1.94 -2.02% NASDAQ: EVO · 15-min delayed
  • Public · NASDAQ: EVO
  • 4,553 employees
  • Founded 1993
$994.5MMarket cap
4,553Employees
EVONASDAQ
1999IPO

About Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Market cap
$994.5M
NASDAQ: EVO
$1.94 -2.02%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$1.94 $4.34

52-week range

Market cap
$994.5M
Dividend yield
44.66%
Shares outstanding
512.6M
Open
Day range
Prev close
Volume
IPO date
Jun 2, 1999

Evotec SE (EVO) Stock Price

  • Trading 55% below its 52-week high.
  • Pays a dividend yielding about 44.66% annually.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Evotec SE.

Write a review
Newsroom

News about Evotec SE

News & sentiment via Polygon.io

FAQ

Evotec SE: frequently asked questions

Is Evotec SE an American company?

Evotec SE is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is Evotec SE publicly traded?

Yes — Evotec SE is a publicly traded company. Its stock trades under the ticker symbol EVO on the NASDAQ.

What does Evotec SE do?

Evotec SE is an American Pharmaceuticals company in the Health & Beauty sector.

When was Evotec SE founded?

Evotec SE was founded in 1993.

Explore

Similar companies

Browse all →